1 |
Evaluation of Serum Matrix Metalloproteinase-3 as an Objective Indicator for the Disease Activity in Rheumatoid Arthritis Patients Treated With Methotrexate Versus Tocilizumab: 24-week Results From a Prospective Randomized Controlled Study
Jina Yeo, Han Joo Baek, Yeong Wook Song, Eun Young Lee
J Rheum Dis.2022;29(2):89-97. Published online 2022 April 1
DOI: http://dx.doi.org/10.4078/jrd.2022.29.2.89
|
|
2 |
Matrix Metallopeptidase 3 Polymorphisms: Emerging genetic Markers in Human Breast Cancer Metastasis
Shafinah Ahmad Suhaimi, Soon Choy Chan, Rozita Rosli
J Breast Cancer.2020;23(1):1-9. Published online 2020 February 18
DOI: http://dx.doi.org/10.4048/jbc.2020.23.e17
|
|
3 |
Matrix Metalloproteinase-3 Gene Polymorphism is Associated with Coronary Artery Calcification Scores in Patients with Type 2 Diabetes Mellitus
Sang-Wook Kim, Eun Hee Cho
Korean Diabetes J.2009;33(2):113-123. Published online 2009 April 30
DOI: http://dx.doi.org/10.4093/kdj.2009.33.2.113
|
|